Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2100570 | 0.79 | CYP2C19 (0.42) | CYP2C19HIF1AMAPK1TAAR1ALDH1A1 | |
| SCHEMBL8366810 | 0.77 | TAAR1 (0.48) | CYP2C19HIF1AMAPK1TAAR1ALDH1A1 | |
| SCHEMBL1197506 | 0.76 | KCNN4 (0.32) | MAPK1KCNN4 | |
| SCHEMBL6323709 | 0.75 | KIF11 (0.40) | MAPK1TAAR1ALDH1A1ALOX15KCNN4 | |
| SCHEMBL5413472 | 0.75 | MAPK1 (0.38) | CYP2C19HIF1AMAPK1TAAR1ALDH1A1 | |
| SCHEMBL17710390 | 0.72 | CYP2C19 (0.47) | CYP2C19HIF1AMAPK1TAAR1ALDH1A1 | |
| SCHEMBL3644944 | 0.67 | TAAR1 (0.45) | CYP2C19HIF1AMAPK1TAAR1ALDH1A1 | |
| SCHEMBL812875 | 0.66 | CYP2C19 (0.48) | CYP2C19HIF1AMAPK1TAAR1ALDH1A1 | |
| SCHEMBL1502452 | 0.65 | TAAR1 (0.58) | CYP2C19HIF1AMAPK1TAAR1ALDH1A1 | |
| SCHEMBL28272853 | 0.65 | TAAR1 (0.46) | CYP2C19HIF1AMAPK1TAAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12554198-B2 | Functional hydrogen silsesquioxane resins and the use thereof | PIBOND OY (FI) | 2026-02-17 | — | — | US | disclosed |
| US-20250326936-A1 | ARTICLES INCLUDING SURFACE COATINGS AND METHODS TO PRODUCE THEM | MAXTERIAL INC (US) | 2025-10-23 | — | — | US | disclosed |
| US-12173166-B2 | Articles including surface coatings and methods to produce them | MAXTERIAL, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-20230295827-A1 | COATINGS AND COATED SURFACES INCLUDING LOW-SURFACE ENERGY INORGANIC PARTICLES | MAXTERIAL INC (US) | 2023-09-21 | — | — | US | disclosed |
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | JSI SILICONE CO. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11542621-B1 | Coatings and coated surfaces including low-surface energy inorganic particles | MAXTERIAL, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-20220162391-A1 | Functional hydrogen silsesquioxane resins and the use thereof | PIBOND OY (FI) | 2022-05-26 | — | — | US | disclosed |
| US-20220016624-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR SAMPLE PROCESSING | 10X GENOMICS, INC. | 2022-01-20 | — | — | US | disclosed |
| EP-3931639-A1 | FUNCTIONAL HYDROGEN SILSESQUIOXANE RESINS AND THE USE THEREOF | Pibond Oy (FI) | 2022-01-05 | — | — | EP | disclosed |
| US-11046794-B2 | Scale inhibitor compositions and methods of using | CYTEC INDUSTRIES INC. (US) | 2021-06-29 | — | — | US | disclosed |
| US-20160159660-A1 | SILICON CONTAINING POLYMER FLOCCULANTS | CYTEC INDUSTRIES INC. (US) | 2016-06-09 | — | — | US | disclosed |
| US-20150191646-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2015-07-09 | — | — | US | disclosed |
| US-9012377-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES INCORPORATED (US) | 2015-04-21 | — | — | US | disclosed |
| WO-2014106007-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2014-07-03 | — | — | WO | disclosed |
| US-20140187449-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2014-07-03 | — | — | US | disclosed |
| US-8501326-B2 | Wax replacement specialty formulated corrugating adhesive | HENKEL CORPORATION (US) | 2013-08-06 | — | — | US | disclosed |
| US-20110259945-A1 | WAX REPLACEMENT SPECIALTY FORMULATED CORRUGATING ADHESIVE | HENKEL AG & CO. KGAA (DE) | 2011-10-27 | — | — | US | disclosed |
| WO-2010080973-A2 | WAX REPLACEMENT SPECIALTY FORMULATED CORRUGATING ADHESIVE | HENKEL CORPORATION (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-2010054134-A1 | WATERBORNE ADHESIVE | HENKEL CORPORATION (US) | 2010-05-14 | — | — | WO | disclosed |
| US-20100119741-A1 | Waterborne Adhesive | HENKEL CORPORATION | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | PFAS, FRK, AGPAT2 | CYP2C19 384/4885HIF1A 2300/4885MAPK1 1365/4885 |
| US-12554198-B2 | Functional hydrogen silsesquioxane resins and the use thereof | MACF1, RTF1, ERCC4 | CYP2C19 2368/4885HIF1A 214/4885MAPK1 2966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.